UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

LCC-Demons: A robust and accurate symmetric diffeomorphic registration algorithm

NeuroImage (Orlando, Fla.), 2013-11, Vol.81 (1), p.470-483

2013

Volltextzugriff (PDF)

2020 update on the clinical validity of cerebrospinal fluid amyloid, tau, and phospho-tau as biomarkers for Alzheimer’s disease in the context of a structured 5-phase development framework

European journal of nuclear medicine and molecular imaging, 2021-07, Vol.48 (7), p.2121-2139

2021

Volltextzugriff (PDF)

Clinical validity of second-generation tau PET tracers as biomarkers for Alzheimer’s disease in the context of a structured 5-phase development framework

European journal of nuclear medicine and molecular imaging, 2021-07, Vol.48 (7), p.2110-2120

2021

Volltextzugriff (PDF)

The validation status of blood biomarkers of amyloid and phospho-tau assessed with the 5-phase development framework for AD biomarkers

European journal of nuclear medicine and molecular imaging, 2021-07, Vol.48 (7), p.2140-2156

2021

Volltextzugriff (PDF)

Current and emerging avenues for Alzheimer's disease drug targets

Journal of internal medicine, 2019-10, Vol.286 (4), p.398-437

2019

Volltextzugriff (PDF)

EFNS task force: the use of neuroimaging in the diagnosis of dementia

European journal of neurology, 2012-12, Vol.19 (12), p.1487-1501

2012

Volltextzugriff (PDF)

Clinical validity of increased cortical uptake of [18F]flortaucipir on PET as a biomarker for Alzheimer’s disease in the context of a structured 5-phase biomarker development framework

European journal of nuclear medicine and molecular imaging, 2021-07, Vol.48 (7), p.2097-2109

2021

Volltextzugriff (PDF)

Mild cognitive impairment (MCI) in medical practice: a critical review of the concept and new diagnostic procedure. Report of the MCI Working Group of the European Consortium on Alzheimer’s Disease

Journal of Neurology, Neurosurgery and Psychiatry, 2006-06, Vol.77 (6), p.714-718

2006

Volltextzugriff (PDF)

A European Academy of Neurology guideline on medical management issues in dementia

European journal of neurology, 2020-10, Vol.27 (10), p.1805-1820

2020

Volltextzugriff (PDF)

MCI patients’ EEGs show group differences between those who progress and those who do not progress to AD

Neurobiology of aging, 2011-04, Vol.32 (4), p.563-571

2011

Volltextzugriff (PDF)

Detection of grey matter loss in mild Alzheimer's disease with voxel based morphometry

Journal of neurology, neurosurgery and psychiatry, 2002-12, Vol.73 (6), p.657-664

2002

Volltextzugriff (PDF)

In vivo mapping of amyloid toxicity in Alzheimer disease

Neurology, 2009-04, Vol.72 (17), p.1504-1511

2009

Volltextzugriff (PDF)

Structural correlates of early and late onset Alzheimer’s disease: voxel based morphometric study

Journal of neurology, neurosurgery and psychiatry, 2005-01, Vol.76 (1), p.112-114

2005

Volltextzugriff (PDF)

Musical and psychomotor interventions for cognitive, sensorimotor, and cerebral decline in patients with Mild Cognitive Impairment (COPE): a study protocol for a multicentric randomized controlled study

BMC geriatrics, 2023-02, Vol.23 (1), p.76-20, Article 76

2023

Volltextzugriff (PDF)

Local amygdala structural differences with 3T MRI in patients with Alzheimer disease

Neurology, 2011-02, Vol.76 (8), p.727-733

2011

Volltextzugriff (PDF)

A voxel based morphometry study on mild cognitive impairment

Journal of neurology, neurosurgery and psychiatry, 2005-01, Vol.76 (1), p.11-14

2005

Volltextzugriff (PDF)

EEG markers are associated to gray matter changes in thalamus and basal ganglia in subjects with mild cognitive impairment

NeuroImage (Orlando, Fla.), 2012-03, Vol.60 (1), p.489-496

2012

Volltextzugriff (PDF)

Increase of theta/gamma ratio is associated with memory impairment

Clinical neurophysiology, 2009-02, Vol.120 (2), p.295-303

2009

Volltextzugriff (PDF)

Hippocampal atrophy and EEG markers in subjects with mild cognitive impairment

Clinical neurophysiology, 2007-12, Vol.118 (12), p.2716-2729

2007

Volltextzugriff (PDF)

The dynamics of Alzheimer's disease biomarkers in the Alzheimer's Disease Neuroimaging Initiative cohort

Neurobiology of aging, 2010-08, Vol.31 (8), p.1263-1274

2010

Volltextzugriff (PDF)

Clinical diagnosis of Alzheimer's disease: recommendations of the International Working Group

Lancet neurology, 2021-06, Vol.20 (6), p.484-496

2021

Volltextzugriff (PDF)

Medial temporal atrophy but not memory deficit predicts progression to dementia in patients with mild cognitive impairment

Journal of neurology, neurosurgery and psychiatry, 2006-11, Vol.77 (11), p.1219-1222

2006

Volltextzugriff (PDF)

In vivo neuropathology of the hippocampal formation in AD: A radial mapping MR-based study

NeuroImage (Orlando, Fla.), 2006-08, Vol.32 (1), p.104-110

2006

Volltextzugriff (PDF)

The new Alzheimer’s criteria in a naturalistic series of patients with mild cognitive impairment

Journal of neurology, 2010-12, Vol.257 (12), p.2004-2014

2010

Volltextzugriff (PDF)

Autonomic dysfunction in mild cognitive impairment: a transcranial Doppler study

Acta neurologica Scandinavica, 2011-12, Vol.124 (6), p.403-409

2011

Volltextzugriff (PDF)

1 – 25 von 589

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(551)
Mit Volltextzugriff
(458)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)
... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

LCC-Demons: A robust and accurate symmetric diffeomorphic registration algorithm

2020 update on the clinical validity of cerebrospinal fluid amyloid, tau, and phospho-tau as biomarkers for Alzheimer’s disease in the context of a structured 5-phase development framework

Clinical validity of second-generation tau PET tracers as biomarkers for Alzheimer’s disease in the context of a structured 5-phase development framework

The validation status of blood biomarkers of amyloid and phospho-tau assessed with the 5-phase development framework for AD biomarkers

Current and emerging avenues for Alzheimer's disease drug targets

EFNS task force: the use of neuroimaging in the diagnosis of dementia

Clinical validity of increased cortical uptake of [18F]flortaucipir on PET as a biomarker for Alzheimer’s disease in the context of a structured 5-phase biomarker development framework

Mild cognitive impairment (MCI) in medical practice: a critical review of the concept and new diagnostic procedure. Report of the MCI Working Group of the European Consortium on Alzheimer’s Disease

A European Academy of Neurology guideline on medical management issues in dementia

MCI patients’ EEGs show group differences between those who progress and those who do not progress to AD

Detection of grey matter loss in mild Alzheimer's disease with voxel based morphometry

In vivo mapping of amyloid toxicity in Alzheimer disease

Structural correlates of early and late onset Alzheimer’s disease: voxel based morphometric study

Musical and psychomotor interventions for cognitive, sensorimotor, and cerebral decline in patients with Mild Cognitive Impairment (COPE): a study protocol for a multicentric randomized controlled study

Local amygdala structural differences with 3T MRI in patients with Alzheimer disease

A voxel based morphometry study on mild cognitive impairment

EEG markers are associated to gray matter changes in thalamus and basal ganglia in subjects with mild cognitive impairment

Increase of theta/gamma ratio is associated with memory impairment

Hippocampal atrophy and EEG markers in subjects with mild cognitive impairment

The dynamics of Alzheimer's disease biomarkers in the Alzheimer's Disease Neuroimaging Initiative cohort

Clinical diagnosis of Alzheimer's disease: recommendations of the International Working Group

Medial temporal atrophy but not memory deficit predicts progression to dementia in patients with mild cognitive impairment

In vivo neuropathology of the hippocampal formation in AD: A radial mapping MR-based study

The new Alzheimer’s criteria in a naturalistic series of patients with mild cognitive impairment

Autonomic dysfunction in mild cognitive impairment: a transcranial Doppler study

Suchergebnisse filtern